Weight Loss — Unintentional Algorithm

Safety

Red Flags — Significant Unexplained Weight Loss

Done

Significant unexplained weight loss: assess urgently for cancer, organic disease, malnutrition and psychosocial causes. A loss of around 5% or more over 6–12 months is clinically significant and should prompt assessment. NICE NG12 (updated April 2026, rec 1.13.2) specifically recommends, for age 60 and over with unexplained weight loss of more than 5% within 6 months, assessing for additional symptoms, signs or findings, then offering urgent investigation, a suspected cancer pathway referral, or a non-specific symptoms pathway referral. The probability of cancer is increased in older adults but varies substantially with age, sex, associated symptoms and examination findings.

Weight loss + dysphagia Dysphagia requires urgent assessment for oesophageal or upper-GI cancer, irrespective of age (a referral trigger, not a diagnosis). In people aged 55 and over, weight loss with upper abdominal pain, reflux or dyspepsia warrants a suspected cancer pathway referral (NICE NG12 (updated April 2026)).

Weight loss + lower-GI features Offer FIT per NICE NG12 age/symptom criteria: abdominal mass; change in bowel habit; iron-deficiency anaemia; age 40+ with unexplained weight loss and abdominal pain; under 50 with rectal bleeding plus abdominal pain or weight loss; 50+ with rectal bleeding, abdominal pain or weight loss → FIT ≥10 µg Hb/g faeces = suspected cancer pathway referral. FIT should not delay referral where there is a rectal or abdominal mass, significant clinical concern or inability to obtain a sample. FIT below 10 µg Hb/g does not exclude colorectal cancer — safety-net persistent or progressive symptoms.

Weight loss + visible haematuria Adults aged 45 and over with unexplained visible haematuria, or visible haematuria that persists or recurs after successful UTI treatment → urology suspected cancer pathway referral (NICE NG12) (renal cell carcinoma, transitional cell carcinoma). Non-visible haematuria has separate criteria.

Weight loss + haemoptysis Refer using the suspected cancer pathway for unexplained haemoptysis in adults aged 40 and over (lung, NICE NG12). Separately, offer an urgent CXR (within 2 weeks) at 40 and over for 2 or more unexplained symptoms (cough, fatigue, shortness of breath, chest pain, weight loss, appetite loss), or 1 or more — including unexplained weight loss alone — in anyone who has ever smoked (NICE NG12).

Weight loss + jaundice Pancreatic / biliary / hepatic malignancy → age ≥40 with jaundice: suspected cancer pathway (NICE NG12) + urgent LFTs / USS abdomen — urgent hepatobiliary assessment

Age 60+ with weight loss + pancreatic-associated symptoms In adults aged 60 and over with unexplained weight loss plus diarrhoea, back pain, abdominal pain, nausea, vomiting, constipation or new-onset diabetes, consider urgent direct-access CT (or ultrasound if CT is unavailable) for pancreatic cancer (NICE NG12). Not automatic in younger adults without relevant symptoms.

Night sweats + lymphadenopathy Possible lymphoma — assess node size, site, duration, consistency and mobility; supraclavicular or generalised nodes; fever, night sweats and weight loss; abnormal FBC, LDH or blood film; infection risk and recent vaccinations → refer using local lymphoma/haematology criteria (not every small reactive node with night sweats)

Bone pain + weight loss Myeloma, bony metastases → age 60+ with persistent bone pain (particularly back pain) or unexplained fracture: myeloma screen — FBC, calcium, ESR or plasma viscosity, serum protein electrophoresis, serum free light chains (urine Bence Jones if free light chains unavailable). A negative electrophoresis does not exclude light-chain myeloma

Postmenopausal bleeding + weight loss Endometrial / ovarian cancer → assess and refer according to the current NICE NG12 gynaecological cancer recommendations and local gynaecology pathway (not limited to age 55 and over)

NICE NG12 (updated April 2026) recommends suspected cancer pathway referrals for specific symptom combinations with weight loss. Most unintentional weight loss is not due to cancer. The probability of cancer rises with age and with organ-specific symptoms (dysphagia, haemoptysis, rectal bleeding), and varies with sex and examination findings — avoid fixed percentages unless the population and source are stated. Use the NG12 criteria and the non-specific symptoms pathway to avoid missing cancer while keeping the assessment balanced.

Diagnose

Quantify & Characterise — History

Done

Quantify weight loss

Weigh patient now — compare to recorded weights; calculate percentage loss and time course. Around 5% or more over 6–12 months is clinically significant (NICE NG12 cancer criterion: >5% within 6 months, age 60+). If no previous weights, a strong clinical history (belt/clothing size change, family observations) is useful. Assess BMI, frailty and muscle loss. Unintentional loss >10% within 3–6 months, or >5% with BMI <20, meets the NICE malnutrition criteria (CG32) — complete MUST and act on it

Intentional or not?

Dietary change, increased exercise, GLP-1 agonists, new medication — confirm unintentional before investigating. If intentional + disordered pattern → eating disorder screen

Appetite

Preserved appetite + weight loss → malabsorption (coeliac, IBD, pancreatic insufficiency), diabetes, hyperthyroidism. Reduced appetite → depression, malignancy, infection

GI symptoms

Dysphagia, vomiting, diarrhoea, steatorrhoea (pale, floating, offensive stool = malabsorption), PR bleeding, change in bowel habit

Systemic symptoms

Fever, night sweats, fatigue (B-symptoms → haematological malignancy). Polydipsia / polyuria (diabetes). Tremor, heat intolerance, palpitations (hyperthyroidism)

Psychosocial

Depression (most common non-organic cause in elderly), anxiety, social isolation, financial difficulties (food insecurity), bereavement, dementia (forgetting to eat)

Also ask

Appetite and intake, swallowing, medication, alcohol, mood, cognition, dentition, finances and ability to shop/cook

Preserved appetite with weight loss strongly suggests a hypermetabolic state (hyperthyroidism, uncontrolled diabetes) or malabsorption rather than malignancy or depression. This distinction narrows the differential significantly. Steatorrhoea (the hallmark of fat malabsorption) is a key symptom patients rarely volunteer — direct questioning is needed. In elderly patients, depression is a common cause of unintentional weight loss and is frequently missed — ask directly about mood (e.g. PHQ-9 where appropriate).

Diagnose

Differential Diagnosis Framework

Done

Malignancy

More likely with increasing age. Any organ system. Weight loss can precede other symptoms by months. Probability varies with age, sex, associated symptoms and examination findings — refer according to NG12 age/symptom criteria.

Non-malignant organic (GI, endocrine/metabolic, infection/inflammation, cardiopulmonary/renal/hepatic)

Hyperthyroidism, uncontrolled diabetes (type 1 or 2), Addison's disease, COPD, heart failure, CKD, cirrhosis, IBD, coeliac disease, TB, HIV, chronic infection

Psychiatric / eating disorder

Depression (most common in elderly), anxiety, anorexia nervosa / ARFID (all ages), late-onset psychosis, substance misuse (alcohol, stimulants)

Malabsorption

Coeliac disease (preserved appetite + diarrhoea + fatigue), exocrine pancreatic insufficiency, small bowel bacterial overgrowth, post-surgical (gastrectomy, short bowel)

Medication-related

GLP-1 agonists (semaglutide, liraglutide), SGLT2 inhibitors, metformin (nausea), SSRIs initially, stimulants, digoxin toxicity, opioids (nausea)

Social / nutritional / measurement

Food insecurity, isolation, dentition, functional barriers to shopping/cooking; normal variation or measurement error (different scales, clothing). If no cause is found but loss persists, reassess clinically and use the local non-specific symptoms pathway — not passive watchful waiting.

Use a qualitative framework rather than a fixed distribution: malignancy; gastrointestinal/malabsorption; endocrine/metabolic; infection/inflammation; cardiopulmonary/renal/hepatic disease; medication/substance-related; psychiatric/eating disorder; social and nutritional causes; normal variation or measurement error. Where no cause is found but weight loss persists, reassess clinically rather than wait passively. Coeliac disease is frequently diagnosed late — check coeliac serology (while the patient is eating gluten) with diarrhoea, bloating, iron deficiency or malabsorption.

Diagnose

Targeted Examination

Done

Weight & BMI

Weigh and calculate BMI. Document BMI — low weight with fear of weight gain or distorted body image → assess for an eating disorder; do not use BMI alone to diagnose or decide on referral (NICE NG69). Assess muscle mass (MUAC) if frail.

General appearance

Cachexia (muscle wasting + fat loss), lymphadenopathy, jaundice, pallor, clubbing, oedema

Thyroid

Goitre, tremor, lid lag, warm peripheries, AF — hyperthyroidism. Weight loss with preserved appetite + palpitations → TFTs urgently

Abdominal exam

Hepatomegaly (metastases, cirrhosis, haematological), splenomegaly (haematological malignancy, portal hypertension), masses, ascites, PR examination

Lymph nodes

Cervical, axillary, inguinal, supraclavicular (Virchow's node — left supraclavicular = upper GI malignancy, highly significant)

Other systems

Hydration, chest, cardiovascular status, oral/dental status; pelvic examination where clinically indicated

Rectal exam

Where it will answer a clinical question — rectal bleeding, palpable mass, altered bowel habit or anorectal symptoms (rectal mass, blood on examining finger). Not mandatory on age alone.

Breasts / testes

Symptom- and context-led — examine if there is a lump or relevant symptom; a new lump + weight loss needs the relevant suspected cancer pathway.

Mental state

Mood (PHQ-9 where appropriate) and suicide risk; cognitive assessment with an appropriate validated tool if impairment is observed or reported (not routine for weight loss alone); eating disorder signs (Russell's sign, parotid enlargement, lanugo hair)

Virchow's node (left supraclavicular lymphadenopathy — Troisier's sign) is a highly significant finding indicating metastatic upper GI, lung, or other intra-abdominal malignancy — this needs the relevant suspected cancer pathway referral. Russell's sign (calluses on dorsum of knuckles from self-induced vomiting) and parotid enlargement suggest bulimia nervosa. Rectal examination is indicated where it will answer a clinical question — rectal bleeding, a palpable mass, altered bowel habit or anorectal symptoms.

Diagnose

Investigations — Systematic Screen

Done

Initial tests — guided by history and examination

Urine dipstick FBC U&E/eGFR LFTs TFTs CRP/ESR HbA1c Calcium Albumin (malnutrition marker)

Targeted cancer tests

PSA (only after shared decision-making where urinary/prostate or metastatic symptoms, an abnormal prostate examination or significant concern make it appropriate — not on age alone) · Myeloma screen (age 60+ with persistent bone pain or unexplained fracture: FBC, calcium, ESR/plasma viscosity, serum protein electrophoresis, serum free light chains; urine Bence Jones if SFLC unavailable) · CEA / CA-125 only if specific clinical indication — not routine cancer markers

Malabsorption screen

Anti-TTG IgA + IgA level (coeliac — if diarrhoea, bloating, iron deficiency or malabsorption; patient eating gluten) · Faecal elastase (only where steatorrhoea or pancreatic exocrine insufficiency is suspected) · B12 / folate (macrocytosis, neurological symptoms, nutritional risk or malabsorption) · Iron studies (anaemia, bleeding risk or dietary concern)

Infection screen

HIV test (according to risk and local testing policy) · CXR (if respiratory/systemic features or cancer/infection concern) · Urine MC&S if urinary symptoms or abnormal dipstick · No routine blood cultures in an afebrile patient

Imaging

CXR — if respiratory/systemic features or cancer/infection concern, per NG12 (not for all patients) — but offer an urgent CXR (within 2 weeks) at 40 and over for unexplained weight loss in anyone who has ever smoked, or with another unexplained symptom (cough, fatigue, shortness of breath, chest pain, appetite loss). USS abdomen/pelvis if abdominal symptoms, jaundice, hepatomegaly. CT: urgent direct-access CT where NICE NG12 applies (for example, pancreatic: aged 60 and over with weight loss plus diarrhoea, back pain, abdominal pain, nausea, vomiting, constipation or new-onset diabetes); otherwise via the suspected cancer pathway.

NOT routinely

CA-19-9, AFP, CEA without specific clinical indication — poor specificity, causes anxiety and over-investigation. PSA in symptomatic prostate disease only. Not as a universal panel: CXR, HIV, PSA, SPEP, faecal elastase or blood cultures for all.

CXR is useful where there are respiratory or systemic features or cancer/infection concern — it can identify lung cancer, TB, heart failure and mediastinal lymphadenopathy — but it is not needed for every patient with weight loss. The exception to remember: NICE NG12 offers an urgent CXR (within 2 weeks) at 40 and over for unexplained weight loss in anyone who has ever smoked, or for weight loss plus one other unexplained symptom. Serum albumin <35 g/L is a powerful predictor of malnutrition and increased mortality risk — it should prompt nutritional assessment (MUST) and an individualised nutrition plan. Routine cancer markers (CEA, CA-125, AFP) have poor specificity and low positive predictive value in the absence of clinical features — they generate more false positives than true positives in unselected patients.

Refer

Referral — Suspected cancer and Urgent Pathways

Done

999 / same-day

999: physiological instability, haemodynamic instability from GI bleeding, suspected sepsis (NICE NG253) or acute decompensation. Same-day medical assessment: severe malnutrition (do not rely on BMI alone) or inability to eat/drink.

Suspected cancer: upper GI

NICE NG12 (updated April 2026): dysphagia (any age), or age ≥55 with weight loss plus upper abdominal pain, reflux or dyspepsia → suspected cancer pathway referral; upper abdominal mass consistent with stomach cancer → consider a suspected cancer pathway referral.

Suspected cancer: colorectal

NICE NG12 (updated April 2026) referral criteria: FIT ≥10 µg Hb/g faeces in adults with an abdominal mass, change in bowel habit, iron-deficiency anaemia, age 40+ with unexplained weight loss and abdominal pain, under 50 with rectal bleeding plus abdominal pain or weight loss, or 50+ with rectal bleeding, abdominal pain or weight loss → suspected cancer pathway. Rectal or abdominal mass, significant concern or no sample → refer directly. FIT <10 does not exclude cancer — safety-net

Suspected cancer: lung

NICE NG12: age ≥40 with unexplained haemoptysis, or CXR suggesting lung cancer → suspected cancer pathway. Separately, offer an urgent CXR (performed within 2 weeks) to adults aged 40 and over with 2 or more unexplained symptoms from cough, fatigue, shortness of breath, chest pain, weight loss and appetite loss — or 1 or more if they have ever smoked. Unexplained weight loss alone in an ever-smoker aged 40 and over therefore meets the NG12 threshold for an urgent CXR

Suspected cancer: haematology

Lymphadenopathy with concerning features (size, site, supraclavicular/generalised, persistence, B-symptoms, abnormal FBC/LDH/film) per local lymphoma/haematology criteria. Myeloma: abnormal myeloma screen or paraprotein

Other NG12 pathways

Age 60+ with weight loss plus pancreatic-associated symptoms → consider urgent direct-access CT (or ultrasound). Visible haematuria (age 45+, unexplained or persisting after UTI treatment) → urology. Jaundice at age 40+ → suspected cancer pathway referral (pancreatic) with urgent LFTs / USS abdomen. Postmenopausal bleeding → gynaecology pathway. Ascites or a pelvic or abdominal mass (not obviously uterine fibroids) → gynaecology suspected cancer pathway (ovarian). Unexplained bruising, bleeding or petechiae, pallor or hepatosplenomegaly → very urgent FBC (within 48 hours) to assess for leukaemia. Age 60+ with unexplained weight loss >5% in 6 months and no site-specific feature → urgent investigation or non-specific symptoms pathway

Eating disorders

Suspected anorexia nervosa, ARFID or bulimia requires specialist eating-disorder assessment. Arrange same-day medical assessment where there is physiological instability, severe electrolyte abnormality, dehydration, syncope, severe bradycardia, hypotension/postural drop, hypothermia, ECG abnormality, rapid weight loss, purging, severe malnutrition or high suicide risk (RCPsych MEED 2022). Do not rely on BMI alone. Refer stable cases to the community eating disorder service (NICE NG69) and signpost the BEAT charity. Do NOT manage alone in primary care.

Dietitian

Complete MUST (Malnutrition Universal Screening Tool) where appropriate and act on the score. A score of 2 or more indicates high risk and should prompt an individualised nutrition plan, review of reversible causes, consideration of dietetic referral and monitoring. Prescribe oral nutritional supplements only when clinically indicated and consistent with local formulary/ACBS requirements

NICE NG12 suspected cancer referral thresholds are based on positive predictive value — the combinations listed carry ≥3% PPV for the relevant cancer. Anorexia nervosa has the highest mortality of any psychiatric disorder — RCPsych MEED (2022) grades BMI below 13 as high (red) risk and 13–14.9 as amber, but BMI must be interpreted alongside rate of weight loss, cardiovascular, temperature, electrolyte, ECG, hydration and suicide-risk markers. Malnutrition affects 3 million people in the UK (BAPEN data) — MUST identifies people at risk who need an individualised nutrition plan, with dietitian input for those at high risk where appropriate. Delaying dietitian referral worsens outcomes in cancer and chronic disease.

Treat

GP Management — Nutritional Support & Condition-Specific

Done

Malnutrition (MUST ≥2)

Nutrition plan ± oral nutritional supplements

Individualised nutrition plan, review of reversible causes, consideration of dietetic referral and monitoring. Prescribe ONS (e.g. Ensure Plus / Fortisip) only when clinically indicated and per local formulary/ACBS requirements. Energy and protein targets are dietitian-led and patient-specific.

Hyperthyroidism

Carbimazole — after confirmed diagnosis

Only after confirmed biochemical diagnosis and appropriate clinical assessment. Baseline FBC and LFTs; clear agranulocytosis counselling. Dose depends on severity and local endocrinology guidance. Refer endocrinology.

Coeliac disease

Gluten-free diet

Confirm diagnosis first (coeliac serology while the patient is consuming gluten; BSG pathway). Then life-long strict GFD with dietitian input after diagnosis. Check B12, folate, iron, vitamin D, calcium — often deficient. Annual review including coeliac antibody titre.

DepressionFirst assess the depressive syndrome, suicide risk, bipolarity, eating disorder, substance use and medical causes — do not automatically prescribe for weight loss with low mood. Treat per NICE depression guidance (NHS Talking Therapies ± antidepressant where indicated); mirtazapine may suit depression with poor appetite but is not an appetite stimulant. Monitor weight. If eating disorder + depression → specialist referral.

Pancreatic insufficiencyOnly after confirmation (e.g. faecal elastase) or strong clinical suspicion: pancreatic enzyme replacement (Creon) — dose adjusted to fat content of meals. Dietitian involvement. Address cause (chronic pancreatitis, pancreatic cancer).

Unexplained weight lossNot passive watchful waiting: review within 2–4 weeks; repeat bloods according to abnormalities and trajectory; if loss persists, reassess clinically and use the local non-specific symptoms / rapid diagnostic pathway where suspicion persists. Treat the underlying cause rather than prescribing appetite stimulants empirically. Document clearly.

Next steps: see Malnutrition · Eating disorders · Coeliac disease · Hyperthyroidism · Depression

Oral nutritional supplements (ONS) prescribed on FP10 are ACBS-approved and can be a cost-effective intervention for malnutrition when clinically indicated — they reduce hospital admissions, infection rates, and mortality in malnourished patients. Carbimazole carries a risk of agranulocytosis — patients must be warned to seek immediate review if they develop sore throat or fever and an FBC arranged urgently. Strict lifelong gluten-free diet resolves most coeliac symptoms and normalises intestinal architecture.

Lifestyle

Nutritional Rehabilitation & Support

Done

Nutritional fortification Add calories to food — butter, full-fat milk, cheese, nut butters, avocado. Agree an individual nutritional plan (any energy targets are dietitian-led). Small frequent meals if appetite poor.

Social eating Encourage meals with family, friends, or community dining. Refer to local community meals service if socially isolated elderly patient.

Appetite stimulation Small portions, favourite foods, timing meals with social occasion. Megestrol acetate (appetite stimulant) in cancer cachexia — specialist use only. Mirtazapine may be selected for a patient with depression and poor appetite where clinically appropriate, but should not be used solely as an appetite stimulant.

Exercise (preserve muscle) Resistance exercise preserves muscle mass during weight loss. Even light walking + gentle strength training prevents sarcopaenia. Physiotherapy referral if severely deconditioned.

Alcohol review Alcohol displaces nutrition (empty calories + poor absorption). AUDIT-C. Alcohol dependence → alcohol specialist service referral. Oral thiamine for harmful or dependent drinkers who are malnourished or at risk of malnutrition (NICE CG100). Suspected Wernicke's encephalopathy (confusion, ataxia, eye-movement signs) is a medical emergency → immediate hospital transfer; give parenteral thiamine (e.g. Pabrinex, per local protocol) urgently if available, without delaying transfer. Oral thiamine is not adequate for suspected Wernicke's (NICE CG100).

Food insecurity Assess practical barriers — finances, ability to shop/cook, dentition (poor teeth = reduced intake). Signpost to local food banks, social prescribing, Meals on Wheels, community care.

Dental review Poor dentition is a major underdiagnosed cause of weight loss in elderly — pain on chewing reduces intake. Urgent dental referral if significant dental disease.

MUST monitoring Repeat MUST score monthly in patients with active weight loss. Weight trend chart — GP clinical system weight record is an underused resource for monitoring.

Food insecurity affects approximately 8% of UK adults (Food Foundation 2023) and is significantly higher in elderly, disabled, and low-income patients — it is a common and completely reversible cause of weight loss that is missed without direct questioning. Sarcopaenia (muscle loss) associated with malnutrition is a major predictor of functional decline and mortality in the elderly — resistance exercise alongside nutritional rehabilitation preserves muscle far better than nutrition alone. Mirtazapine (H1 and 5-HT2C antagonism) may be chosen for a patient with depression and poor appetite where clinically appropriate, but not solely as an appetite stimulant.

Safety

Follow-Up & Safety-Netting

Done

2–4 weeks

Review if weight loss is continuing, tests are abnormal or pending, investigations are negative but concern persists, nutritional risk is significant, or there is frailty or social vulnerability. Any new symptoms pointing to a specific diagnosis?

3 months

If no diagnosis and loss persists, reassess clinically — not passive watchful waiting. Repeat bloods according to abnormalities and trajectory. Repeat CXR only if there is a respiratory indication. Use the local non-specific symptoms / rapid diagnostic pathway where suspicion persists.

Longer term

Review weight trajectory on clinical grounds; reassess promptly if loss resumes or new symptoms emerge. No routine annual cancer surveillance after negative investigation.

Carbimazole monitoring

TFTs at 4–6 weeks after starting, then 2–3 monthly. FBC if sore throat/fever (agranulocytosis). Refer endocrinology for definitive treatment (radioiodine or surgery).

Anorexia nervosa

Physical risk monitoring agreed with the eating-disorder service (MEED): weight trajectory, heart rate, BP and postural drop, temperature, electrolytes, ECG (QTc), hydration, SUSS (sit up–squat–stand) test and suicide risk. SCOFF is a screening questionnaire, not a monitoring or medical-risk tool

999 safety-net

Haematemesis / melaena, haemoptysis with haemodynamic compromise, collapse, severe confusion

Same-day GP

Rapid deterioration or acceleration of weight loss, inability to eat/drink, new alarm symptom (dysphagia, haemoptysis, rectal bleeding), jaundice appearing, severe malnutrition or physiological instability

"No cause found" is not a reassuring endpoint if weight loss persists — it requires clinical reassessment and, where suspicion persists, the non-specific symptoms pathway, rather than routine repeat tests or passive surveillance. In anorexia nervosa, bradycardia (<50 bpm) and QTc prolongation are the most life-threatening signs — ECG is a key monitoring tool and QTc prolongation (MEED red: above 450 ms in females, above 430 ms in males) needs same-day medical assessment (RCPsych MEED 2022). The SCOFF questionnaire is a 5-question screen for possible eating disorders; the SUSS test assesses muscle strength as a physical risk marker.